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During a comparative study of the content of adenosine triphosphate 
(ATP) in the erythrocytes of glucose-6-phosphate dehydrogenase (G-6-PD) 
deficient and normal subjects, a G-6-PD deficient Negro man who exhibited 
twice the normal level of ATP in his erythrocytee was observed (Brewer, 
June, 1964). Bis level of ATP was 6-7 standard deviations above the nor- 
mal mean. The family of this individual has been studied and the results 
indicate that this abnormality of ATP metabolism irs inherited. The study 
of the family, in addition to the results of a survey of the Negro pop- 
ulation carried out while looking for other examples of the abnormality, 
form the basis of this report. 
Materials and Method.9 
Subjects: The propositus of the family with elevated erythrocytic 
ATP and most of the other affected members of the kindred are clinically 
and hematologically normal. The unrelated Negro male and female sub- 
jects forming the control group were primarily individuals from whom 
blood samples were drawn in the outpatient laboratory, University Hos- 
pital, University of Michigan Medical School, Ann Arbor, Michigan, either 
at the time of routine pre-employment physical examination, or while pre- 
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senting with one of a variety of minor illnesses. Patients with major 
systemic disease or hematologic disorders were excluded. 
Methods: Venous blood was anticoagulated immediately after removal 
from the vein with 0.15 ml. of acid-citrate-dextrose solution (NIH For- 
mula A) per 1.0 ml. of blood and kept at 4O C. until used. Assay of 
ATP content of the erythrocytes was performed within 24 hours of collec- 
tion of the blood. Protein-free extracts of the erythrocytes were pre- 
pared by the trichloroacetic acid extraction method of Bartlett (1959). 
TABLE 1 
Erythrocytic ATP Levels, Blood Types, Hemoglobin Types, and 
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Control Erythrocytic ATP Values - 
119 Negro Hales 3.14 f 0.42 
t 
Mean f one S.D, 
130 Negro Females 3.25 f 0.56 Mean f one S.D. 
+ See Figure 1. 
* An h sign indicates that the ATP value is considered abnormally high. 
- Blood types reveal exclusion of II-13 as the biological father. 
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Adenosine triphosphate was assayed spectrophotometrically by a modifica- 
tion of the enzymatic method of Kornberg (1950) using the hexokinase 
and G-6-PD reactions to reduce triphosphopyridine nucleotide. Details 
of the assay method will be published. Hemoglobin types were deter- 
mined by starch gel electrophoresis. Deficiency of G-6-PD activity was 
determined both by assay of hemolysates for G-6-PD activity by the meth- 
od of Zinkham and Lenhard (1959) and by the methemoglobin reduction test 
(Brewer, Tarlov, and Alving, l$G and 1962). 
Results and Discussion 
The erythrocytic ATP values of various members of the kindred are 




Tl?m!D - Nmuu 
Fig. 1. Pedigree of the kindred with elevated erythrocytic ATP. 
Males and females whose red cell ATP values are above two standard 
deviations from the mean of their respective control distributions 
have arbitrarily been designated as affected. 
included in Table 1 are results of tests for G-6-PD deficiency and 
sickle hemoglobin, and results of blood group studies. Individuals 
whose erythrocytic ATP values are above two standard deviations from 
the control mean (males and females compared separately) have arbi- 
trarily been designated as affected with elevated erythrocytic ATP. 
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Two males in the family (II-9 and 1X1-4) have levels of ATP in 
their red cells a8 high as that of the propositue. A number of other 
individuals, including one female (II->), have intermediately elevated 
values. Considerable variation in expression of the trait, even within 
a sibship, is present. For example, a half-brother of the propositus 
(II-~), who has intermediately elevated levels, has one affected son 
with very high levels (X11-4), and a second affected son with slightly 
elevated values (111-2). This, of course, represents male to male 
transmission of the trait and indicates an autosomal mode of inheritance. 
A full sister of the propositus (X-11) demonstrates lack of penetrance 
of the trait, i.e. she has two affected sons, but she has a normal level 
of erythrocytic ATP. 
We interpret the data so far as being compatible with single factor 
autosomal inheritance of elevated erythrocytic ATP. All of the affected 
individuals are presumably heterozygous for the gene. The genes for 
sickle cell trait and G-6-PD deficiency segregate independently from the 
elevated ATP trait in the kindred. 
In both the male and female control distributions there were two 
outlying values above two standard deviations from the control mean. The 
values were 4.11 and 4.42 for the male individuals and 4.56 and 4.57 for 
the female subjects. Studies of the families of these individuals will 
be necessary to determine if they represent additional examples of inher- 
ited elevated erythrocytic ATP. Even so, until we have identified the 
primary biochemical abnormality, it will not be possible to conclude that 
any two given families with elevated erythrocytic ATP have the same spe- 
cific abnormality. If these individuals should eventually prove to have 
the same abnormality, the incidence of the condition in the Negro popula- 
tion would be significant, i.e. between one and two percent. 
One of the more important aspects of this new genetic trait may 
be its use as a tool for evaluating the role of ATP in various cellular 
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functions. As two examples of such an application, we have used this 
trait in evaluation of the role of ATP in G-6-PD deficiency-type drug- 
induced hemolytic anemia, and in evaluation of the role of ATP in long 
term blood storage (Brewer and Powell, 196k). 
Subsequent to our first report of elevated erythrocytic ATP (Brewer, 
June, l#+), Zurcher, Loos and Prins (September, 1964) reported another 
family with what they have termed "hereditary high ATP content of the 
erythrocytes". The family reported by these authors appears to repre- 
sent an entity distinct from the one we have reported. In their family, 
the authors believe that they can fully explain the metabolic abnormal- 
ities present by an increased activity of pyruvic kinase in the erythro- 
cytes of affected individuals. In our family, the activity of pyruvic 
kinase is normal in red cells of subjects with elevated erythrocytic ATP. 
We have as yet not identified the primary biochemical abnormality 
in the erythrocytes of affected individuals from our family. Work in 
this area, as well as work on the tissue distribution of the abnormality, 
is in progress. 
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